4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-15-003485
CIK 0001369786operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 3:57 PM ET
Size
5.5 KB
Accession
0001181431-15-003485
Insider Transaction Report
Form 4
Krizman Anthony
Director
Transactions
- Award
Restricted Stock Units
2015-02-25+1,841→ 1,841 total→ Common Stock (1,841 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of SGNT common stock.
- [F2]The restricted stock units vest in four equal annual installments beginning on February 25, 2016. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 3:57 PM ET
- Size
- 5.5 KB